PTC Therapeutics ($PTCT) CFO Gravier Pierre sold company shares on the open market three times over the past year, for a total of about $497,000. His latest sale occurred on February 18, 2026. These transactions rank 6,470th out of 11,678 individual insiders by sale value in our database, well below the average of $8.6 million across 6.4 transactions per seller. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 2992 | $69.36 | 87,318.0000 | 88,311,494 | 3.31% | 0.00% |
| Jan. 6, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 2139 | $76.95 | 90,310.0000 | 88,311,494 | 2.31% | 0.00% |
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Common Stock | 20000 | $0.00 | 92,449.0000 | 88,311,494 | 27.61% | 0.02% |
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 88,311,494 | 9999.99% | 0.06% |
| July 15, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 2516 | $49.46 | 71,920.0000 | 78,151,240 | 3.38% | 0.00% |
| May 23, 2025 | FILANA THERAPEUTICS, INC. | $FLNA | Gravier Pierre | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| Feb. 20, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 1167 | $50.12 | 74,436.0000 | 76,845,055 | 1.54% | 0.00% |
| Feb. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 1168 | $50.10 | 75,603.0000 | 76,845,055 | 1.52% | 0.00% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 56250 | $0.00 | 56,250.0000 | 76,845,055 | 9999.99% | 0.07% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Common Stock | 22500 | $0.00 | 76,771.0000 | 76,845,055 | 41.46% | 0.03% |
| July 16, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | S | Common Stock | 2269 | $34.02 | 53,531.0000 | 76,725,070 | 4.07% | 0.00% |
| May 9, 2024 | FILANA THERAPEUTICS, INC. | $FLNA | Gravier Pierre | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 74,838,292 | 9999.99% | 0.06% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Common Stock | 3100 | $0.00 | 55,800.0000 | 74,838,292 | 5.88% | 0.00% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Common Stock | 19000 | $0.00 | 52,700.0000 | 74,838,292 | 56.38% | 0.03% |
| Dec. 12, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | P | Common Stock | 7700 | $25.81 | 33,700.0000 | 75,377,997 | 29.62% | 0.01% |
| July 13, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 74,730,433 | 9999.99% | 0.09% |
| July 13, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Gravier Pierre | CHIEF FINANCIAL OFFICER | A | Common Stock | 26000 | $0.00 | 26,000.0000 | 74,730,433 | 9999.99% | 0.03% |